Lesiones ampollares en una paciente con morfea panesclerótica discapacitante de la infancia

Lola Kuperman Wilder; Candela Preti; César Chiappe; Gabriela Bendjuia

doi:10.47196/da.v27i3.2127

Authors

Lola Kuperman Wilder J. M. Ramos Mejía General Acute Hospital, Autonomous City of Buenos Aires, Argentina
Candela Preti J. M. Ramos Mejía General Acute Hospital, Autonomous City of Buenos Aires, Argentina
César Chiappe J. M. Ramos Mejía General Acute Hospital, Autonomous City of Buenos Aires, Argentina
Gabriela Bendjuia J. M. Ramos Mejía General Acute Hospital, Autonomous City of Buenos Aires, Argentina

DOI:

https://doi.org/10.47196/da.v27i3.2127

Keywords:

morphea, bullae, bullous lichen sclerosus

Abstract

Bullous morphea is an infrequent type of morphea characterized for developing bullae on sclerodermiformic plaques. The presence of bullae forces to discard lichen sclerosus, a disease that usually develops in the genital zone, the extragenital variant could belong to the same spectrum that localized sclerodermiformic diseases. We present a 19 year old female patient with the diagnosis of panesclerotic morphea and bullous lichen sclerosus.

Author Biographies

Lola Kuperman Wilder, J. M. Ramos Mejía General Acute Hospital, Autonomous City of Buenos Aires, Argentina

Resident Physician

Candela Preti, J. M. Ramos Mejía General Acute Hospital, Autonomous City of Buenos Aires, Argentina

Dermatologist, Collagen Diseases Sector

César Chiappe, J. M. Ramos Mejía General Acute Hospital, Autonomous City of Buenos Aires, Argentina

Pathologist

Gabriela Bendjuia, J. M. Ramos Mejía General Acute Hospital, Autonomous City of Buenos Aires, Argentina

Dermatologist, Collagen Diseases Sector

References

I.. Sánchez-Pérez S, Escandell-González I, Pinazo-Canales MI, Jordá-Cuevas E. Bullous morphea: description of a new case and discussion of etiologic and pathogenic factors in bulla formation. Actas Dermosi liogr. 2017;108:75-76.

II. Daoud MS, Su WP, Leiferman KM, Perniciaro C. Bullous morphea: Clinical, pathological and immunopathologic evaluation of thirteen cases. J Am Acad Dermatol. 1994;30:937-943.

III. Uitto J, Santa Cruz DJ, Bauer EA, Eisen AZ. Morphea and lichen sclerosus et atrophicus. Clinical and histopathologic studies in patients with combined features. J Am Acad Dermatol. 1980;3:271-279.

IV. Yasar S, Mumcuoglu CT, Serdar ZA, Gunes P. A case of lichen sclerosus et atrophicus accompanying bullous morphea. Ann Dermatol. 2011;23:354-359.

V. López Bertrán JM, Renis FM, Stefanazzi MH, Simionato C, et ál. Liquen escleroso extragenital ampollar y hemorrágico: a propósito de un caso [en línea]. Rev Argent Dermatol. 2010;91(3). [Consultado marzo 2021].

Rencic A, Goyal S, Mofid M, Wigley F, et ál. Bullous lesions scleroderma. Int J Dermatol. 2020;41:335-339.

VII. Mertens JS, Marsman D, Van de Kerkhof PC, https://pubmed. ncbi.nlm.nih.gov/12100687/ Hoppenreijs EP, et ál. Use of mycophenolate mofetil in patients with severe localized scleroderma resistant or intolerant to methotrexate. Acta Derm Venereol. 2016;96:510-513.

VIII. Arthur M, Fett NM, Latour E, Jacobe H, et ál. Evaluation of the e ectiveness and tolerability of mycophenolate mofetil and mycophenolic acid for the treatment of morphea. JAMA Dermatol. 2020;156: 521-528.